These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
859 related articles for article (PubMed ID: 27852046)
1. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046 [TBL] [Abstract][Full Text] [Related]
2. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation? Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318 [TBL] [Abstract][Full Text] [Related]
3. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma? Solmaz S; Uzun O; Acar C; Sevindik OG; Piskin O; Ozsan HG; Demirkan F; Undar B; Alacacioglu A; Ozcan MA; Alacacioglu I J Lab Physicians; 2018; 10(4):363-369. PubMed ID: 30498304 [TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303 [TBL] [Abstract][Full Text] [Related]
5. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer. Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study. Cai C; Zeng W; Wang H; Ren S Int J Chron Obstruct Pulmon Dis; 2024; 19():933-943. PubMed ID: 38646605 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy. Miao Y; Yan Q; Li S; Li B; Feng Y Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290 [TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study. Fan Z; Li Y; Ji H; Jian X BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133 [TBL] [Abstract][Full Text] [Related]
9. Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma. Li Y; Li H; Li W; Wang L; Yan Z; Yao Y; Yao R; Xu K; Li Z J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27925303 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254 [TBL] [Abstract][Full Text] [Related]
11. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
12. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer]. Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215 [No Abstract] [Full Text] [Related]
13. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio associated with 28-day all-cause mortality in septic patients with coronary artery disease: a retrospective analysis of MIMIC-IV database. Li X; Chen Y; Yuan Q; Zhou H; Lu L; Guo R BMC Infect Dis; 2024 Jul; 24(1):749. PubMed ID: 39075364 [TBL] [Abstract][Full Text] [Related]
15. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort. Yuan C; Li N; Mao X; Liu Z; Ou W; Wang SY Thorac Cancer; 2017 Jul; 8(4):350-358. PubMed ID: 28544400 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: Two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors. Wang L; Ruan M; Yan H; Lei B; Sun X; Chang C; Liu L; Xie W Cytokine; 2020 Sep; 133():155149. PubMed ID: 32512341 [TBL] [Abstract][Full Text] [Related]
18. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Yao C; Liu X; Tang Z Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856 [TBL] [Abstract][Full Text] [Related]
19. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]